Three continuous glucose monitoring systems were shown to provide similar accuracy in adults with type 1 diabetes compared with self-monitoring blood glucose, according to findings published in the Journal of Diabetes Science and Technology.

“Since some CGM systems are already intended for nonadjunctive use, that is, as a replacement for SMBG measurements, and may therefore be used for therapeutic decisions, accuracy and reliability of CGM values have also become important in terms of patient safety,” Guido Freckmann, MD, head of research and development for the Institute of Diabetes Technology, Research and Development at the University of Ulm, Germany, and colleagues wrote.